\
&
Contact us
\
&
Contact us
This was 4 years ago
LocationOnline
ProgrammesOnce a year, the World Health Summit gathers together international experts from academia, politics, the private sector, and civil society. During the three-day summit, stakeholders and decision-makers from 100 countries and every field in healthcare work together to find solutions to global health challenges and set the agenda for a healthier future.
The World Health Summit’s central topics in 2021 include:
Digital participation is free and possible without prior registration.
All keynote sessions, panel discussions and workshops will be available online with Q&A function to join the discussion. The individual Zoom links can be accessed directly in the respective session in the online program: www.conference.worldhealthsummit.org/Program/WHS2021
More information on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Digital, Industry & Space Digital Europe
Health Climate, Energy, Mobility Agro-Food, Environment Missions
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
